The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine
- PMID: 16409215
- DOI: 10.1111/j.1743-6109.2005.00196.x
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine
Abstract
Introduction: Erectile dysfunction (ED) is a highly prevalent disorder associated with a significant burden of illness. The prevalence and incidence of ED are strongly age-related, affecting more than half of men >60 years. The first Princeton Consensus Conference (Princeton I) in 1999 developed guidelines for safe management of cardiac patients regarding sexual activity and the treatment of ED.
Aim: The second conference (Princeton II) was convened to update the recommendations based on the expanding knowledge base and new treatments available. This article reviews and expands on the Princeton II guidelines to address sexual dysfunction and cardiac risk.
Methods: A consensus panel of experts reviewed recent multinational studies in safety and drug interaction data for three phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil), with emphasis on the safety of these agents in men with ED and concomitant cardiovascular disease.
Results: Erectile dysfunction is an early symptom or harbinger of cardiovascular disease, due to the common risk factors and pathophysiology mediated through endothelial dysfunction. Major comorbidities include diabetes, hypertension, hyperlipidemia and heart disease. Any asymptomatic man who presents with ED that does not have an obvious cause (e.g., trauma) should be screened for vascular disease and have blood glucose, lipids, and blood pressure measurements. Ideally, all patients at risk but asymptomatic for coronary disease should undergo an elective exercise electrocardiogram to facilitate risk stratification. Lifestyle intervention in ED, specifically weight loss and increased physical activity, particularly in patients with ED and concomitant cardiovascular disease, is literature-supported.
Conclusions: The recognition of ED as a warning sign of silent vascular disease has led to the concept that a man with ED and no cardiac symptoms is a cardiac (or vascular) patient until proven otherwise. Men with ED and other cardiovascular risk factors (e.g., obesity, sedentary lifestyle) should be counseled in lifestyle modification.
Similar articles
-
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).Am J Cardiol. 2005 Jul 15;96(2):313-21. doi: 10.1016/j.amjcard.2005.03.065. Am J Cardiol. 2005. PMID: 16018863 Review.
-
[Sex, erectile dysfunction, and the heart: a growing problem].Herz. 2003 Jun;28(4):284-90. doi: 10.1007/s00059-003-2478-8. Herz. 2003. PMID: 12825143 Review. German.
-
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).Am J Cardiol. 2005 Dec 26;96(12B):85M-93M. doi: 10.1016/j.amjcard.2005.12.018. Epub 2005 Dec 27. Am J Cardiol. 2005. PMID: 16387575
-
[The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].Przegl Lek. 2009;66(4):192-7. Przegl Lek. 2009. PMID: 19708509 Review. Polish.
-
Erectile dysfunction in the cardiac patient: how common and should we treat?J Urol. 2003 Aug;170(2 Pt 2):S46-50; discussion S50. doi: 10.1097/01.ju.0000075055.34506.59. J Urol. 2003. PMID: 12853773 Review.
Cited by
-
The importance of risk factor reduction in erectile dysfunction.Curr Urol Rep. 2007 Nov;8(6):463-6. doi: 10.1007/s11934-007-0049-x. Curr Urol Rep. 2007. PMID: 18042325 Review.
-
Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA.Int J Clin Pract. 2016 Dec;70(12):1012-1018. doi: 10.1111/ijcp.12908. Int J Clin Pract. 2016. PMID: 28032424 Free PMC article.
-
Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment.Int J Hypertens. 2012;2012:627278. doi: 10.1155/2012/627278. Epub 2012 May 9. Int J Hypertens. 2012. PMID: 22649713 Free PMC article.
-
[Erectile dysfunction].Wien Med Wochenschr. 2009;159(21-22):529-34. doi: 10.1007/s10354-009-0719-z. Wien Med Wochenschr. 2009. PMID: 19997838 German.
-
Effect of tadalafil combined with atorvastatin on hemodynamics and sexual function in middle-aged and elderly patients with hyperlipidemia complicated with erectile dysfunction.Pak J Med Sci. 2021 Nov-Dec;37(7):1965-1971. doi: 10.12669/pjms.37.7.4257. Pak J Med Sci. 2021. PMID: 34912427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical